{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/new-talvey-talquetamab-tgvs-plus-darzalex-faspro-daratumumab-and-hyaluronidase-fihj-data-demonstrate-the-strength-of-a-bispecific-combination-in-earlier-line-relapsed-or-refractory-multiple-myeloma-302799599.html", "message": "News view counter 798399 successfully enlarged"}